Wei Kang was sitting in the office, looking at the freshly released financial report.

Last year's financial report came out relatively late, and it was not delivered to his desk until the end of January.

The overall performance of the sixth year is quite gratifying, and it still maintains a high-speed growth, with revenue exceeding the 70 billion mark, reaching as high as 78.2 billion US dollars.

Compared with the previous year, the growth point of performance is mainly in the field of medical equipment, which can be described as making rapid progress, which is extremely eye-catching.

Portable color ultrasound, portable medical kit, and capsule gastroenteroscope are very popular in China, and are also highly sought after abroad, contributing a lot of sales.

This is not counting artificial blood and nano-pills. After these two are launched, this year's performance will definitely hit a new high.

If it wins the market in the field of endoscopy again, Sanqing's equipment business will be firmly established.

Wei Kang looked at the data of the pharmaceutical business, and frowned.

As he expected, the sales growth of HIV treatment drugs has disappeared, and it is estimated that it will gradually decline in the next year or two.

After all HIV-infected people in China have been cured, the only ones that can support sales are overseas developed countries.

After the HIV patients in Eagle Country and Europa are cured, this once king of anti-AIDS will surely go downhill.

In two or three years, I am afraid that it will become a niche and unpopular drug, and it will no longer be able to bring much income to the company.

The only remaining achievement in the field of anti-AIDS is Duanailing. The price of this drug has been greatly reduced, so it has become the first choice for the treatment of AIDS patients in many developing countries.

Seeing such a result, Wei Kang couldn't help laughing bitterly.

Sure enough, the research and development of this kind of drug that can be completely cured by one shot is purely digging for oneself. No wonder the major pharmaceutical companies are unwilling to do such stupid things anymore, but have developed antihypertensive drugs and hypoglycemic drugs that require a long time. medications taken.

Drugs that continue to generate income for drug companies are the real cash cows and ace drugs.

Even if their effects are not so good, they can't cure the patient, but can only control the disease, but they can keep the patient's wallet open and continue to lose money.

Although it is a trickle, it can still converge into rivers and seas, filling the coffers of pharmaceutical companies.

Instead of breaking out for two or three years like now, and then cutting it in half, it quickly disappeared.

Sanqing is now facing the same situation as Gilead back then.

Inventing drugs that work so well and wipe out patients so cleanly that they indirectly kill their own businesses.

In fact, most pharmaceutical companies with a single product category are facing such a dilemma.

Even pharmaceutical giants like Pfizer, Bayer, and Novartis still have the same troubles.

Unlike Gilead, pharmaceutical giants and small and medium-sized pharmaceutical companies are worried about the expiration of patented drugs.

No matter how effective or powerful the drug is, there is only a 20-year patent. When the patent expires, pharmaceutical companies will be able to capture less and less profit.

If there is no new flagship drug, pharmaceutical companies will lose their leading position in the past, and even lose this market completely under the impact of generic drugs.

The difficulty of new drug research and development can be said to be extremely difficult, and many pharmaceutical companies have declined like this.

The way pharmaceutical giants solve this problem is to buy, buy, buy.

Spend hundreds of millions and billions to buy promising new drug projects, complete clinical trials, and push them to the market to create new ace drugs.

Anyway, they have a lot of money, and they pinch everywhere. As long as they buy a few more pipelines, they will always occupy a lot of holes.

Fortunately, Sanqing is not Gilead, and it does not rely solely on this ace drug to survive.

Nor is Pfizer, who must rely on the ability to continue its glory.

Anti-AIDS drugs are only one of Sanqing's many original drugs, which is why Weikang has the confidence to push them to the market.

Without anti-AIDS drugs, Sanqing also has anti-cancer drugs, anti-AD drugs, and a series of new drugs.

As long as there is a steady stream of new drugs coming out every year, Sanqing will be able to maintain the current momentum and move forward at full speed on track.

Years of investment in research and development have now begun to bear fruit.

Sanqing's current independent research and development capabilities are also very strong, and it is able to develop several original research new drugs every year.

Therefore, Wei Kang is full of confidence and feels that he will definitely not fall into the situation of Gilead.

As soon as he thought of Gilead, he immediately dug out the latest quarterly financial reports of the major pharmaceutical giants.

"Haha, it turns out that Gilead's anti-AIDS drug market is also shrinking, even shrinking faster than Sanqing."

Looking at the opponent's quarterly report, Wei Kang couldn't help laughing.

"It seems that if it can't make a comeback in hepatitis B drugs, I'm afraid the name Gilead will soon fall out of the top 20 and become an unknown person."

"Hopefully they can find a new flashpoint."

Wei Kang shook his head, this is really success or failure, even if the market share reaches 60% or 80% with only one or two ace drugs, so what?

When the patient is cured, the pharmaceutical company disappears.

As a pharmaceutical company, he knows better than anyone else the principle that if you don't advance, you will retreat.

Only by constantly innovating and advancing can we survive in this cruel market and continue to grab excess profits.

But this is also related to the field of Gilead's specialization.

Antiviral drugs are very different from other drugs, and they deal with microorganisms such as viruses.

Like antibiotics and the immune system, it is a life-and-death battle between them and their invading rivals, and the winner must be decided.

The two simply cannot coexist peacefully and live together under the same roof.

The drugs for treating diabetes are a supplement to the lack of insulin in the body. Just like eating and drinking water, they need to be ingested continuously to maintain the balance of the body's basic functions.

Obviously, in the eyes of pharmaceutical companies, the latter is a good business with sustainable development.

Wei Kang continued to read the quarterly reports of Johnson \u0026 Johnson and Pfizer, and soon, a happy smile appeared on his face.

"Finally surpassed Pfizer." He clenched his fist and waved it in the air excitedly.

"If there are no accidents, Sanqing's revenue last year should be the second largest in the pharmaceutical industry, second only to Johnson \u0026 Johnson."

"Of course, this includes the revenue of Sanqing's device business. If we only compare the revenue of drugs, it is still not as good as Pfizer."

"It's not a big problem. Sanqing is also constantly launching new drugs, and will soon completely surpass Pfizer in the field of pharmaceuticals."

"In the sixth year, Sanqing has finally ascended to the second place in the world, and the future is promising."

Thinking of this, Wei Kang couldn't help laughing out loud.

He lay back casually, leaning against the soft and thick back of the chair, his whole body relaxed, and his expression became leisurely.

"Actually, the champion is nothing more than that. He just relies on years of accumulation and is too big to fail. In the past few years, Johnson \u0026 Johnson has been complacent. In the field of pharmaceuticals and equipment, there are no breakthrough results. Hehe, for Sanqing, it is completely Vulnerable."

"Next year, Sanqing will gain a firm foothold in the field of equipment, and with a two-pronged approach, it will definitely defeat Johnson \u0026 Johnson and become the champion."

"At that time, the entire medical field will be ruled by Sanqing."

"The progress of human medical technology should be led by Sanqing."

Today's New Year's Eve, I will do housework during the day and watch the Spring Festival Gala with my parents at night, so I only need to update 2000 words.

I wish you all a happy new year and a prosperous Year of the Rabbit. Happy New Year to everyone!

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like